Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Circ Cardiovasc Interv. 2014 Oct 21;7(6):829–836. doi: 10.1161/CIRCINTERVENTIONS.114.001395

Table 1.

Baseline characteristics

Characteristic All Patients n=519 Any Complication
Yes n=254 No n=265 p-value
Age (years) 83.4±7.5 84.1±7.3 82.8±7.6 0.053
Female 47 52 41 0.010
Prior bypass surgery 39 32 46 0.002
Prior angioplasty 31 28 34 0.12
Peripheral vascular disease 39 42 37 0.22
Creatinine (mg/dL) 1.30±0.48 1.31±0.49 1.28±0.47 0.54
Renal disease (Cr ≥2) 19 21 17 0.22
Ejection fraction (%) 52.9±13.7 53.7±14.0 52.2±13.3 0.35
Ejection fraction <40% 17 17 17 0.98
Oxygen-dep. lung disease 13 14 13 0.56
Body mass index (kg/m2) 27.1±7.2 26.9±7.1 27.3±7.4 0.50
Body mass index <20 kg/m2 10 11 9 0.65
Diabetes mellitus 39 38 40 0.67
Major arrhythmia 48 50 46 0.41
Hemoglobin (mg/dL) 11.7±1.6 11.5±1.5 11.8±1.6 0.026
Systolic BP (mmHg) 127.3±22.0 128.4±22.1 126.3±21.9 0.28
Mini Mental Status Exam (points) 26.8±3.4 26.8±3.4 26.8±3.4 0.98
6MWT attempted 57 52 62 0.035
6MWT distance (m) 156.6±109.4 153.1±98.0 159.4±117.9 0.63
NYHA class 0.17
  2 6 8 5
  3 44 42 46
  4 50 50 49
Mean AV gradient (mmHg) 43.5±14.8 43.9±15.1 43.1±14.5 0.53
Aortic valve area (cm2) 0.65±0.19 0.64±0.18 0.66±0.20 0.26
STS Predicted Mortality (%) 11.6±4.3 11.9±4.8 11.4±3.8 0.17
Cohort A 66 57 76 <0.001
Transfemoral approach 80 81 80 0.84

Values are expressed as mean ± SD or %.